RecruitingNot ApplicableNCT05364892

Biocollection of Patients With ANCA Associated Vasculitis

Biocollection of Patients With ANCA Associated Vasculitis Diagnosed Within the CERAINO Autoimmune Disease Reference Center, Part of the Global BRAISE Project (B-dependent Rare AutoImmune DiseaSES

Sponsor

University Hospital, Brest

Enrollment

100 participants

Start Date

Oct 27, 2022

Study Type

INTERVENTIONAL

Conditions

ANCA-associated Vasculitis

Summary

As rare disease, vasculitis affects a small number of patients, the cohorts available in the literature are few and the pathophysiological mechanisms remain to be elucidated. The collection of standardized data within a patientheque as part of a multi-year follow-up will facilitate the study of the characteristics of these diseases. This may, in particular, address the main objective of identifying predictors of relapse, as well as secondary objectives for predictive factors of mortality, infectious, cardiovascular or neoplastic complications that affect the prognosis of vasculitis in order to establish a more appropriate management of the patients concerned.

Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria5

Major patients with no upper age limit.
Patients assessed as part of the reference centre for rare autoimmune diseases at the CHRU in Brest.
Patients for whom a diagnosis of ANCA-associated vasculitis is made by the physician in charge of the patient, according to the definitions of the Chapel-Hill Consensus Conference.
Patient affiliated with Social Security
Patient who has signed written informed consent